Search Nonprofits

ICRF was founded in 1975 by a group of American and Canadian medical researchers, oncologists, and lay people who were committed to the growth and development of Israel and to combating the worldwide scourge of cancer. These visionaries were determined to harness Israel's educational and scientific resources in the fight against cancer, while stemming the "brain drain" of Israel's best and brightest scientists. Their solution: providing funds for postdoctoral fellowships for young Israeli M.D's and Ph.D.'s. Their solution worked. In addition to ICRF's many achievements and medical breakthroughs by ICRF-supported scientists, the organization now has operating chapters in six cities in three countries - the United States, Canada and Israel -- with its international headquarters in New York City, plus active Boards of Directors for each chapter, an International Board of Trustees, and International Scientific Council, a Scientific Review Panel and a Scientific Advisory Board.

Our mission is to find a effective treatments and ultimately a cure for fragile X syndrome, the most common inherited cause of autism. We directly fund research grants and fellowships at top universities around the world. FRAXA was founded in 1994 by three parents of children with fragile X. Fragile X Syndrome is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4000 boys and 1 in 6000 girls worldwide, and one in 260 women and 1 in 800 men are carriers. Treatments for fragile X are likely to help people affected by related disorders including autism, Alzheimers, and many other brain disorders.